Serial 97198814
Live / Registered — Registered (as of 09 Apr 2024)
What this means for you
Registered since 09 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97198814
- Registration number
- 7356212
- Mark type
- Design / logo
- Filed
- 31 Dec 2021
- Published for opposition
- 08 Nov 2022
- Registered
- 09 Apr 2024
- Attorney of record
- Enshan Hong
Goods and services
- Class 042 — Scientific and technological services: Scientific research in the field of genetics and genetic engineering; Scientific research consulting in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Medical and scientific research in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Scientific research and development; Scientific research and development of diagnostic methods and test processes; Scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; Scientific consultancy services in the field of research and development of therapies and medical preparations; Provision of scientific expertise in the nature of scientific study and research in the field of medicine; Scientific research and development for medical and veterinary purposes; Medical and scientific research in the field of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease, metabolic diseases; Providing medical and scientific research information, consultancy, and advisory services in the fields of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease; Compiling data for medical and scientific research, clinical trials, and drug admission
Owner
- Revir Therapeutics, Inc., Foster City, CA, US
- Revir Therapeutics, Inc., Foster City, CA, US
- Revir Therapeutics, Inc., Foster City, CA, US
Prosecution history
- 09 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Mar 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Mar 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Feb 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Feb 2024 — ASSIGNED TO LIE
- 06 Oct 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Jul 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Jul 2023 — NON-FINAL ACTION E-MAILED
- 28 Jul 2023 — SU - NON-FINAL ACTION - WRITTEN
- 14 Jul 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Jun 2023 — USE AMENDMENT FILED
- 12 Jul 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL